Man Group
SEM

Man Group’s Select Medical SEM Stock Holding History

Man Group’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.47M Sell
210,395
-89,605
-30% -$1.48M 0.01% 1301
2026
Q1 		$4.89M Buy
+300,000
New +$4.69M 0.01% 1170
2024
Q4 		– Sell
-31,736
Closed -$596K – 2171
2024
Q3 		$596K Sell
31,736
-185,477
-85% -$3.55M ﹤0.01% 1625
2024
Q2 		$4.1M Buy
217,213
+63,451
+41% +$1.08M 0.01% 1090
2024
Q1 		$2.5M Buy
153,762
+239
+0.2% +$3.5K 0.01% 1224
2023
Q4 		$1.94M Buy
+153,523
New +$1.94M 0.01% 1286
2023
Q3 		– Sell
-67,165
Closed -$1.04M – 1726
2023
Q2 		$1.15M Buy
+67,165
New +$1.04M ﹤0.01% 1351
2023
Q1 		– Hold
0
– – – 1212
2022
Q4 		– Sell
-22,836
Closed -$272K – 2185
2022
Q3 		$272K Buy
+22,836
New +$324K ﹤0.01% 1692
2022
Q1 		– Sell
-33,226
Closed -$527K – 2349
2021
Q4 		$527K Sell
33,226
-56,671
-63% -$967K ﹤0.01% 1515
2021
Q3 		$1.75M Sell
89,897
-14,444
-14% -$287K 0.01% 1205
2021
Q2 		$2.38M Sell
104,341
-87,207
-46% -$1.81M 0.01% 1173
2021
Q1 		$3.52M Sell
191,548
-238,929
-56% -$3.92M 0.02% 866
2020
Q4 		$6.42M Sell
430,477
-34,072
-7% -$445K 0.03% 657
2020
Q3 		$5.21M Buy
464,549
+110,164
+31% +$1.08M 0.02% 793
2020
Q2 		$2.81M Sell
354,385
-617,474
-64% -$5.12M 0.01% 923
2020
Q1 		$7.85M Sell
971,859
-140,260
-13% -$1.67M 0.05% 359
2019
Q4 		$14M Buy
1,112,119
+214,509
+24% +$2.31M 0.05% 511
2019
Q3 		$8.01M Sell
897,610
-264,968
-23% -$2.32M 0.03% 661
2019
Q2 		$9.94M Sell
1,162,578
-97,730
-8% -$772K 0.04% 634
2019
Q1 		$9.57M Buy
1,260,308
+182,200
+17% +$1.46M 0.04% 590
2018
Q4 		$8.92M Buy
1,078,108
+608,913
+130% +$5.83M 0.04% 503
2018
Q3 		$4.65M Buy
469,195
+191,357
+69% +$1.98M 0.02% 1040
2018
Q2 		$2.72M Buy
277,838
+29,592
+12% +$291K 0.01% 1239
2018
Q1 		$2.31M Buy
+248,246
New +$2.36M 0.01% 1230

Other funds holding SEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Man Group's SEM Position: Q2 2026 in Review

Man Group reduced its Select Medical (SEM) stake by 30% in Q2 2026, selling an estimated $1.48M and leaving 210,395 shares worth $3.47M. The position accounts for 0.01% of the portfolio, ranked #1301.

Man Group first reported a position in SEM in Q1 2018 and has held it in 24 quarters since. The position peaked at $14M in Q4 2019. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Man Group held 210,395 shares of Select Medical worth $3.47M as of Q2 2026.
  • Man Group sold 89,605 Select Medical shares in Q2 2026, an estimated $1.48M.
  • Select Medical made up 0.01% of Man Group's portfolio in Q2 2026, its #1301 holding.
  • Man Group first reported a position in Select Medical in Q1 2018 and has held it in 24 quarters since.
  • Man Group's Select Medical position peaked at $14M in Q4 2019.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.